The findings of present review show that the dietary lignans arctigenin and sesamin seem to be promising carcinopreventive and anticancer agents. These natural lignans can be used as dietary supplements and pharmaceuticals for prevention and treatment of cancer.A few randomized controlled trials (RCTs) have assessed the effect of brown rice…[Read more]

The findings of present review show that the dietary lignans arctigenin and sesamin seem to be promising carcinopreventive and anticancer agents. These natural lignans can be used as dietary supplements and pharmaceuticals for prevention and treatment of cancer.A few randomized controlled trials (RCTs) have assessed the effect of brown rice…[Read more]

The findings of present review show that the dietary lignans arctigenin and sesamin seem to be promising carcinopreventive and anticancer agents. These natural lignans can be used as dietary supplements and pharmaceuticals for prevention and treatment of cancer.A few randomized controlled trials (RCTs) have assessed the effect of brown rice…[Read more]

The findings of present review show that the dietary lignans arctigenin and sesamin seem to be promising carcinopreventive and anticancer agents. These natural lignans can be used as dietary supplements and pharmaceuticals for prevention and treatment of cancer.A few randomized controlled trials (RCTs) have assessed the effect of brown rice…[Read more]

EU initiatives presented since 2018 may help to increase complementarity between Chinese and European infrastructure development plans and reduce associated risks, such as unsustainable debt or new trade barriers arising from increased competition for Chinese investments. The BRI is about to change physical and digital connectivity within Europe,…[Read more]

EU initiatives presented since 2018 may help to increase complementarity between Chinese and European infrastructure development plans and reduce associated risks, such as unsustainable debt or new trade barriers arising from increased competition for Chinese investments. The BRI is about to change physical and digital connectivity within Europe,…[Read more]

EU initiatives presented since 2018 may help to increase complementarity between Chinese and European infrastructure development plans and reduce associated risks, such as unsustainable debt or new trade barriers arising from increased competition for Chinese investments. The BRI is about to change physical and digital connectivity within Europe,…[Read more]

EU initiatives presented since 2018 may help to increase complementarity between Chinese and European infrastructure development plans and reduce associated risks, such as unsustainable debt or new trade barriers arising from increased competition for Chinese investments. The BRI is about to change physical and digital connectivity within Europe,…[Read more]

Overall, chimeric peptides promote osseointegration by promoting angiogenesis and osteogenesis. Additionally, chimeric peptides with P3&4 were more effective than those with P1&2 in improving osseointegration, which might be ascribed to the capacity of P3&4 to provide a greater range for chimeric peptides to express their activity. This work…[Read more]

Overall, chimeric peptides promote osseointegration by promoting angiogenesis and osteogenesis. Additionally, chimeric peptides with P3&4 were more effective than those with P1&2 in improving osseointegration, which might be ascribed to the capacity of P3&4 to provide a greater range for chimeric peptides to express their activity. This work…[Read more]

Overall, chimeric peptides promote osseointegration by promoting angiogenesis and osteogenesis. Additionally, chimeric peptides with P3&4 were more effective than those with P1&2 in improving osseointegration, which might be ascribed to the capacity of P3&4 to provide a greater range for chimeric peptides to express their activity. This work…[Read more]

Many studies suggest opioid receptor (OPr) dimerization modulates the pharmacological properties of opiates. Specifically, heteromerization between OPr types has been reported to lead to changes in intracellular signaling. Thus, ligands targeting heteromers are expected to be novel therapeutic targets with reduced side effects. The heteromers of…[Read more]